交替区域入肝血流阻断在原发性肝癌手术治疗中的应用效果及对患者肝功能、营养指标的影响#br#

摘要/Abstract

摘要： 目的：探讨交替区域入肝血流阻断在原发性肝癌手术治疗中的应用效果及对患者肝功能、营养指标的影响。方法：以我院2018年5月至2022年9月收治的70例原发性肝癌患者作为研究对象，依照其手术方式的不同分为观察组与对照组，每组各35例。对照组实施常规肝血流阻断治疗，观察组实施交替区域入肝血流阻断治疗，对比两组患者围术期相关指标、手术前后的肝功能指标、血清营养指标。结果：观察组患者肝血流阻断时间、术中出血量、手术时长、术后首次排气时间和住院时间均低于对照组（P＜0.05）。手术前两组患者血清碱性磷酸酶（ALP）、谷丙转氨酶（ALT）、谷草转氨酶（AST）水平比较，差异无统计学意义（P＞0.05）；手术后两组患者血清ALP、ALT和AST水平较手术前均升高，但观察组患者血清ALP、ALT和AST水平均低于对照组（P＜0.05）。手术前，两组患者血清转铁蛋白（TRF）、前白蛋白（PAB）、血清白蛋白（Alb）和血红蛋白（Hb）等营养指标比较，差异无统计学意义（P＞0.05）；手术后两组患者TRF、PAB、Alb、Hb水平均升高，且观察组患者TRF、PAB、Alb、Hb水平均高于对照组（P＜0.05）。结论：与常规肝血流阻断相比，原发性肝癌手术治疗中采取交替区域入肝血流阻断能够减少患者术中出血量和手术时间，促进患者术后康复，而且能够减轻手术对患者肝功能带来的损伤，提升患者术后营养水平。

关键词: 交替区域入肝血流阻断, 原发性肝癌, 营养指标, 肝功能

Abstract: Objective：To explore the effects of intermittent regional hepatic vascular inflow occlusion in the surgical treatment of primary liver cancer and its influence on liver function and nutritional index of the patients. Methods： 70 patients with primary liver cancer admitted to our hospital from May 2018 to September 2022 were selected and were divided into the observation group and the control group according to different surgical methods， with 35 cases in each group. The control group was treated with routine hepatic vascular inflow occlusion during the operation， and the observation group was treated with intermittent regional hepatic vascular inflow occlusion during the operation. The relevant perioperative indexes， liver function indexes before and after surgery， and serum nutritional indexes of the two groups of patients were compared. Results： The time of hepatic vascular inflow occlusion， intraoperative bleeding volume， operation duration， first exhaust time after surgery and hospitalization time of patients in the observation group were lower than those of the control group (P<0.05). Before operation， there was no statistical difference in serum alkaline phosphatase (ALP)， glutamic pyruvic transaminase (ALT)， and glutamic oxalacetic transaminase (AST) levels between the two groups of patients（P＞0.05）. After operation， the serum levels of ALP， ALT， and AST of patients in both two groups increased， and the serum ALP， ALT and AST levels of patients in the observation group were lower than those of the control group (P<0.05).Before operation， there was no statistical difference in serum transferrin (TRF)， prealbumin (PAB)， serum albumin (Alb) and hemoglobin (Hb) levels between the two groups (P>0.05). After operation， the serum TRF， PAB， Alb and Hb levels of patients in both groups increased， and the serum levels of TRF， PAB， Alb and Hb of patients in the observation group were higher than those of the control group (P<0.05). Conclusion： Compared with conventional hepatic vascular inflow occlusion， intermittent regional hepatic vascular inflow occlusion in the surgical treatment of primary liver cancer can reduce intraoperative bleeding， reduce operation duration， promote postoperative recovery of the patients， and reduce the damage caused by surgery to the liver function， improve the postoperative nutritional level of the patients.

Key words: Intermittent regional hepatic vascular inflow occlusion, Primary liver cancer, Nutrition index, Liver function

中图分类号:

R735.7

平胜, 牟亚刚. 交替区域入肝血流阻断在原发性肝癌手术治疗中的应用效果及对患者肝功能、营养指标的影响#br#[J]. 中国医药导刊, 2023, 25(10): 1035-1039.

PING Sheng, MOU Yagang. Effects of Intermittent Regional Hepatic Vascular Inflow Occlusion in the Surgical Treatment of Primary Liver Cancer and Its Influence on Liver Function and Nutritional Index of the Patients#br#[J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2023, 25(10): 1035-1039.

参考文献

[1]Kocarnik JM， Compton K， Dean FE， et al. Cancer incidence， mortality， years of life lost， years lived with disability， and disability-adjusted life years for 29 cancer groups from 2010 to 2019： A systematic analysis for the Global Burden of Disease Study 2019[J]. JAMA Oncol，2022，8(3)：420-444.
[2]Yu Y， Fu J， Xia P， et al. A systematic review and meta-analysis on the efficacy and safety of transcatheter arterial chemoembolization combined with radiofrequency ablation in the treatment of primary liver cancer[J]. Transl Cancer Res，2022，11(5)：1297-1308.
[3]Niu X， Liu J， Feng Z， et al. Short-term efficacy of precise hepatectomy and traditional hepatectomy for primary liver cancer： A systematic review and meta-analysis[J]. J Gastrointest Oncol， 2021，12(6)：3022-3032.
[4]Yu C， Wu S， Zhao J， et al. Evaluation of efficacy， safety and treatment-related outcomes of percutaneous radiofrequency ablation versus partial hepatectomy for small primary liver cancer meeting the Milan criteria： A systematic review and meta-analysis of randomized controlled trials[J]. Clin Res Hepatol Gastroenterol， 2020，44(5)：718-732.
[5]吕德泉.大肝癌腹腔镜肝切除术中两种入肝血流阻断方式的应用效果比较[J].山东医药，2022，62(19)：59-61.
[6]林科灿，刘景丰，曾金华，等. 虚拟肝脏手术规划系统预测肝癌肝切除术后肝功能损害的价值[J]. 中华消化外科杂志，2012，11(2)：116-119.
[7]杨雨，陈晶，陈卫波，等. 交替性区域入肝血流阻断在腹腔镜肝右前叶切除术中的应用分析[J]. 中华肝胆外科杂志，2020，26(3)：161-164.
[8]刘可峰，王伟，范永刚. 新型入肝血流阻断方式对肝癌手术患者的疗效及对其肝，胃肠功能指标及预后的影响[J]. 实用癌症杂志， 2022，37(2)：266-269.
[9]中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗指南(2022年版)[J]. 中国实用外科杂志， 2022，42(3)：241-273.
[10]胡勇军，汪磊，刘宁，等. 间歇性全入肝血流阻断与区域性入肝血流阻断腹腔镜肝切除术治疗原发性肝癌患者术后恢复研究[J]. 实用肝脏病杂志， 2022，25(3)：411-414.
[11]马蕊谦，朱翊，肖婉，等. 腹腔镜肝切除术下展开肝主流阻断技术治疗原发性肝癌的疗效观察[J]. 临床和实验医学杂志， 2021，20(7)：708-712.
[12]卢毅，胡智明，张成武，等. 腹腔镜循中肝静脉和肝后下腔静脉平面右半肝切除治疗原发性肝癌的临床疗效研究[J]. 中华普通外科杂志， 2022， 37(1)：57-59.
[13]李小辉，文武，万仁华，等. 3种入肝血流阻断模式在原发性肝癌肝切除术中应用的比较[J]. 中国普外基础与临床杂志， 2021，28(6)：768-773.
[14]张永涛，谭业栋，张立成，等. 微波消融术联合经导管动脉化疗栓塞对原发性肝癌患者免疫功能，肝功能与生存情况的影响[J]. 癌症进展， 2021， 19(18)：1903-1906.
[15]范志超，于凤姣.交替性入肝血流阻断在腹腔镜肝部分切除中的应用[J].临床医学工程，2023，30(4)：463-464.
[16]位松华.ALT、AST、ALP、γ-GT组合实验室检验结果分析在各类肝胆疾病诊断中的临床价值[J].检验医学与临床，2016，13(6)：848-849.
[17]张旭阳，张莹，盘宁波，等. 不同方式入肝血流阻断法对肝切除手术患者肝脏缺血再灌注损伤的影响分析[J]. 四川解剖学杂志，2020，28(1)：55-56.
[18]李俊，王学文，罗国松. 腹腔镜下解剖性肝切除术对原发性肝癌患者手术指标，无瘤生存率及肝功能的影响[J]. 实用医院临床杂志， 2022， 19(6)：85-88.

快速检索引用检索图表检索高级检索